Biocon Poised to Raise ₹5.70 Billion Through Commercial Papers as Board Meeting Approaches

Unknown Apr 02, 2026 2 Views

Biocon Limited, a leading biopharmaceutical company, is set to consider and potentially approve the issuance of commercial papers worth ₹5.70 billion at its board meeting scheduled for January 27, 2025. This strategic move comes as the company seeks to optimize its capital structure and fund ongo...

Stay Ahead – Explore Now! Stuck on ‘Call Limit Reached’ in Rocket League? Quick Fixes Inside!